Fertility-female
Conditions
Interventions
Micronized vaginal progesterone
Sponsors
Researcher
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Signed informed consent Premenopausal females, age = 19 years = 44 years Non-smokers Normal follicular phase (Day 2-4) hormones (FSH, LH, E2, PRL, T, and TSH Documented history of infertility Normal endovaginal ultrasound at screening Subject is not pregnant Clinically indicated protocol for induction of IVF with a fresh embryo Single or dual embryo transfer BMI = 18 and = 30 kg/m2
Exclusion criteria
Exclusion criteria: Evidence of diseases which could limit participation in or completion of the study Acute urogenital disease Known allergic reactions to progestogens Intake of any other experimental drug or on going treatment of any illness participation in any other clinical trial within 30 days prior to study start Disability or any condition leading to lack of fitness to participate in or to complete the study Current or recent substance abuse, including alcohol and tobacco History of chemotherapy or radiotherapy Patients with more than 3 unsuccessful IVF attempts Women in whom pregnancy is contraindicated Refusal or inability to comply with the requirements of the study protocol for any reason History of recurrent pregnancy loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of Participants With Presence of Fetal Heart Beats at 12 Week's Gestation Determined by endovaginal ultrasound scan | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of Participants With a Positive Biochemical Pregnancy Test on Day 14 After Embryo Transfer;Percentage of Participants With Presence of Fetal Heart Beats at 8 Week's Gestation Determined by endovaginal Ultrasound | — |
Countries
Nigeria
Contacts
Public ContactElizabeth IshoriboKiva
Chief Resident
Outcome results
None listed